POLICY ADVOCATES for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Corporate Tax Reform Legislation Deficit reduction policy issues Tax Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Trade (domestic/foreign) TRD
Trans-Pacific Strategic Economic Partnership Agreement (TPP) Transatlantic Trade and Investment Partnership (TTIP)
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Health Issues HCR
S. 957: Drug Supply Chain Security Act. S. 959: Pharmaceutical Compounding Quality and Accountability Act. S. 214 - The Preserve Access to Affordable Generics Act; provisions relating to patent settlements S. 504 - Fair and Immediate Release of Generic Drugs Act; provisions related to patent settlements
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.